Select a community
All Communities
Home > Community Treatment Reports > Amitiza Treatment Report

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Amitiza Treatment Report

What is Amitiza? Amitza is a brand name for the drug Lubiprostone, a drug used in the treatment of chronic constipation. It works both to soften the stool and initiate bowel movements.

See more information, including instructions, precautions, side effects, and interactions.


Reasons taken

38 patients in the community are taking or have taken Amitiza.

Dosages

Based on the patients currently taking Amitiza.

  2 24mcg as needed 24 mcg weekly 8 mcg daily 16 mcg daily 24 daily 24 mcg daily 48 mcg daily 96 mcg daily
  1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 4 Number of Patients: 4 1 Number of Patients: 1 11 Number of Patients: 11 13 Number of Patients: 13 1 Number of Patients: 1  

Duration

How long current patients have been taking Amitiza or how long patients were taking Amitiza before stopping.

Currently Taking Amitiza

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
2
4
7
8

Stopped Taking Amitiza

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
3
1
0
0
1
0
Why Patients Stopped Taking Amitiza (multiple reasons could be selected)
Reason # Patients Percentage of patients
Side effects too severe 4 67% Side effects too severe: 67%
Other 2 33% Other: 33%
Did not seem to work 1 17% Did not seem to work: 17%
Expense 1 17% Expense: 17%
Personal research 1 17% Personal research: 17%

Patient Reported Evaluations

Results from 6 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Slight 100% 1

Other

Side-effects (as an overall problem)

Severe 0% 0
Moderate 17% 1
Mild 17% 1
None 67% 4

Top reported side-effects include: Sharp chest pains, Nausea/Vomiting

Summary results are based on 6 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (1 of 6)

  • wise1
    Sex: F
    Flare-up: Severe
    Sensation: Severe
    Overall: Moderate
    Cognition: moderate
    Vision: moderate
    Speech: mild
    Swallowing: moderate
    Upper limb: moderate
    Walking: severe
  • wise1
  • by wise1
    Dec 20, 2008
  • EfficacySlight
  • Side-effectsModerate
  • Other
Advice/Tips
the chest pain is unbearable-feels like ur heart is coming through ur ribcage

See all evaluation results for Amitiza

Report created on November 08, 2009.